NCT06066645: An ongoing trial by Glaukos Corporation
This trial is ongoing. It must report results 9 months, 2 weeks from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06066645 |
|---|---|
| Title | Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose® TR (Travoprost Intraocular Implant) in Conjunction With the Placement of iStent Infinite vs. iStent Infinite Alone in Subjects With Open-angle Glaucoma or Ocular Hypertension |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Sept. 14, 2023 |
| Completion date | Feb. 28, 2025 |
| Required reporting date | Feb. 28, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | May 16, 2025 |
| Days late | None |